Achilles Therapeutics (ACHL) Q1 2024 Earnings

May 8Expected
Q1 2023
Q2 2023
Q3 2023
Q1 2024
-0.46
-0.44
-0.42
-0.4

Details

Expected EPS
-0.46
Actual EPS
-0.46
Surprise EPS
0
Surprise Percent
+0%

Description

⁨Achilles Therapeutics⁩ (⁦ACHL⁩) has reported earnings of ⁦-0.46⁩ per share for ⁦Q1 2024⁩.

0 Comments

Share your thoughts